Followers | 422 |
Posts | 30168 |
Boards Moderated | 4 |
Alias Born | 08/08/2004 |
Thursday, September 03, 2015 3:52:25 PM
You could argue it is worth more than a p/e of 15 due to the fact that the company has no debt, liabilities and there is no threat of dilution but I remain conservative.
I think a person with a long term view could hold for .10 realistically and that is just based on 21 licensee agreements and the projected 1.2 mil in net profit in 2016.
As they add more licensees my target price will go up. If they end up with 35 by the end of 2016 as it has been speculated, I will be looking for .30 pps.
Buy and hold. IMO! I wonder if the person selling at .02 a couple of days ago thought he would be able to get back in cheaper?
Real investors are stepping in here. IMO!
Otcbargains Undervalued Penny Plays
http://investorshub.advfn.com/Otcbargains-Undervalued-Penny-Plays-23198/
Recent SCRH News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/08/2023 04:34:23 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/20/2023 09:26:34 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM